HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hakop Gevorkyan Selected Research

Sleepiness

11/2020Safety and pharmacokinetic profiles of MGS0274 besylate (TS-134), a novel metabotropic glutamate 2/3 receptor agonist prodrug, in healthy subjects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hakop Gevorkyan Research Topics

Disease

1Pain (Aches)
12/2023
1Fatigue
12/2023
1Injection Site Reaction
12/2023
1Nausea
11/2020
1Vomiting
11/2020
1Sleepiness
11/2020
1Dizziness (Lightheadedness)
11/2020
1Headache (Headaches)
11/2020
1Vivax Malaria
01/2019
1Asthma (Bronchial Asthma)
06/2018
1Atopic Dermatitis (Atopic Eczema)
06/2018
1Schizophrenia (Dementia Praecox)
10/2016
1Heart Failure
05/2016
1Demyelinating Diseases (Demyelinating Disease)
08/2014
1Multiple Sclerosis
08/2014

Drug/Important Bio-Agent (IBA)

1cabotegravirIBA
12/2023
1Rilpivirine (TMC-278)IBA
12/2023
1tafenoquineIBA
01/2019
1Interleukin-13IBA
06/2018
1tralokinumabIBA
06/2018
1Monoclonal AntibodiesIBA
06/2018
1Dopamine (Intropin)FDA LinkGeneric
10/2016
1Neprilysin (Neutral Endopeptidase)IBA
05/2016
1sacubitril and valsartan sodium hydrate drug combinationIBA
05/2016
1Angiotensin Receptors (Angiotensin II Receptor)IBA
05/2016
1opicinumabIBA
08/2014

Therapy/Procedure

1Contraindications
12/2023
1Oral Administration
11/2020